Chemotherapy Alone for Early-Stage Spinal Tuberculosis

施建党,王自立,耿广起,王沛
DOI: https://doi.org/10.3969/j.issn.1004-406x.2011.10.03
2011-01-01
Abstract:Objective:To evaluate the effect and indication of chemotherapy alone for early-stage spinal tuberculosis.Method:From January 2000 to June 2007,36 patients from the General Hospital of Ningxia Medical University suffering from spinal tuberculosis undergoing anti-TB chemotherapy alone were retrospectively reviewed.The chemotherapeutic regimen was combined medication(3HRZS/1-15HRZ),and the course was 4~18 months.The effect of anti-tuberculosis,including clinical manifestation,the phantom study(bone heals,raised abnormal),the neurofunction and complications related to tuberculosis chemotherapy were reviewed.The chemotherapy course can be adjusted individually according to the result of following up.Result:All cases were followed up for 3-5 years.Of them,16 patients healed with less than 4 months of the short-course chemotherapy.The patients with poor outcome had their course extended to 9 months.14 patients healed completely.The remaining 6 patients healed by 18 months long-range chemotherapy.At final follow-up,all patients had body temperature recovered to normal,weight increased,the local pain disappeared,and the bony union;while 6 cases had kyphosis angle increased(30°,application of external fixation).All patients had ESR decreased to normal.8 cases(22%) presented with the medicine related complications,which resolved after ceasing chemotherapy and responsive intervention.Conclusion:The routine chemotherapy alone is reliable for early-stage spinal tuberculosis.
What problem does this paper attempt to address?